| GTO ID | GTC1430 |
| Trial ID | NCT01676779 |
| Disease | Malignant Adenoma |
| Therapy | mRNA vaccine |
| Treatment | Dendritic cells Vaccines |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Randomized Controlled Phase II Clinical Trial on mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma Patients Who Are Disease-free Following the Local Treatment of Macrometastases. |
| Year | 2012 |
| Country | Belgium |
| Company sponsor | Universitair Ziekenhuis Brussel |
| Other ID(s) | DC-MEL |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||